Journal: The Journal of Clinical Investigation
Article Title: Bone marrow–confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia
doi: 10.1172/JCI152673
Figure Lengend Snippet: ( A ) Cultured MDSL cells were treated with tocilizumab or IgG for 1 hour at indicated concentrations. Cells were then challenged with human recombinant IL-6 (10 ng/mL) for 15 minutes followed by Western blot assay of p-STAT3. Actin was used as a loading control. See complete unedited blots in the supplemental material. ( B ) 1 × 10 4 MDSL cells per well were seeded in a 96-well plate on day 0 in MDSL culture medium with 50 μg/mL tocilizumab or 50 μg/mL human IgG control. Relative cell number was assessed with CCK-8 reagent at indicated time points. ( C ) 1 × 10 6 MDSL cells were transplanted into sublethally irradiated NSG recipient mice. Ten days after transplantation, mice were subjected to weekly tocilizumab (TCZ) or human IgG (8 mg/kg) by i.p. administration. Engraftment was evaluated 60 days after transplantation via flow cytometry assays of hCD45 + mononuclear cells in the peripheral blood. n = 5 in each group. ( D ) Quantification of the percentage of hCD45 + cells in C . ( E and F ) Colony-forming unit (CFU) assays in normal ( E ) and high-risk MDS patient ( F ) bone marrow–derived CD34 + cells. 1 × 10 3 normal ( E ) or 2 × 10 3 patient CD34 + cells ( F ) were seeded in MethoCult medium supplemented with human IgG or tocilizumab (50 μg/mL) on day 0. The number of colonies was assessed on day 14. Triplicate assay colonies were independently identified by 2 individuals. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001; 2-tailed Student’s t test. E, G, M, GM, and GEMM represent BFU/CFU-E, CFU-G, CFU-M, CFU-GM, and CFU-GEMM, respectively, in both E and F .
Article Snippet: Complete blood cell counts (Hemavet 950, Drew Scientific) and flow cytometric analysis (BD FACSCanto II) of the peripheral blood were performed at different time points after transplantation to assess chimeras and engraftment.
Techniques: Cell Culture, Recombinant, Western Blot, Control, CCK-8 Assay, Irradiation, Transplantation Assay, Flow Cytometry, Derivative Assay